Pequot Capital

edit

Pequot Capital Management, Inc. is a U.S. registered investment adviser founded in 1998 by Arthur J. Samberg, Chairman and Chief Executive Officer, to manage the Pequot Family of Funds, which began trading in 1986. The firm manages approximately $5.0 billion in assets as of September 30, 2008 (including approximately $580 million of uncalled committed capital) in multiple strategies. An institutional quality infrastructure and an extensive proprietary research platform supports over 150 employees, with offices in Connecticut, New York, California and London.

Pequot Capital offers a diverse range of investment products tailored to the needs of domestic and offshore investors. Their clients include institutions and sophisticated high net worth investors. They continually evaluate their product line and encourage innovation within the firm.

Milestones

edit

• 
  Pequot Capital invested in EnzymeRx. (5/28/08)
  Posted 6/5/09 at 1:58am
• 
  Pequot Capital invested in Range Fuels. (4/21/08)
  Posted 6/5/09 at 9:02pm
• 
  Pequot Capital invested in Stemline Therapeutics. (4/9/08)
  Posted 6/5/09 at 2:49am
• 
  Pequot Capital invested in RealD. (1/08)
  Posted 3/2/09 at 8:58pm
• 
  Pequot Capital invested in Paracor Medical. (6/29/07)
  Posted 9/11/09 at 11:46pm
• 
  Pequot Capital invested in DiObex. (4/16/07)
  Posted 9/16/09 at 7:45am
• 
  Pequot Capital invested in MAP Pharmaceuticals. (3/28/07)
  Posted 9/15/09 at 5:27am
• 
  Pequot Capital invested in Sanarus Medical. (2/20/07)
  Posted 9/15/09 at 7:25am
• 
  Pequot Capital invested in Scalent Systems. (1/22/07)
  Posted 10/13/08 at 9:24pm
• 
  Pequot Capital invested in Sadra Medical. (10/23/06)
  Posted 6/17/09 at 11:32am
• 
  Pequot Capital invested in Facet Solutions. (12/13/05)
  Posted 11/5/09 at 12:24pm
• 
  Pequot Capital invested in Sadra Medical. (6/17/04)
  Posted 6/17/09 at 11:34am
• 
  Pequot Capital invested in Hammerhead Systems.
  Posted 12/26/08 at 4:03pm

Investments

Videos

Sources

1. EnzymeRx Announces Receipt of $14 million Capital Investment and Acquisition of Pegylated Uricase (enzymerx.com) [edit]
2. Range Fuels raises $100m in biggest deal so far this year (indusbusinessjournal.com) [edit]
3. Capital Funding Report [edit]
4. Digital 3D Cinema Company Real D Raises $20 Million (dmwmedia.com) [edit]
5. Paracor raises $44M for heart-failure device that restrains the heart (venturebeat.com) [edit]
6. DiObex, a metabolic disease treatment co., raises $24M (deals.venturebeat.com) [edit]
7. MAP Pharma raises $50M for respiratory and CNS disease treatments (deals.venturebeat.com) [edit]
8. Sanuras, breat tumor device company raises $15M (deals.venturebeat.com) [edit]
9. Scalent raises $15M for data center virtualization (venturebeat.com) [edit]
10. Sadra Medical Raises $19 Million In Series B Financing (biospace.com) [edit]
11. HealthPoint Capital (healthpointcapital.com) [edit]
12. Citation Needed [add]
13. Venture Beat (venturebeat.com) [edit]